Yulia Tunitsky-Lifshitz

1PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 23, 2023
The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.

Yulia Tunitsky-Lifshitz, Ramit Maoz-Segal, Stanley Niznik

Pageof 1

Frequent Collaborators